Tai Anh Vu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tai Anh Vu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ecosse Luc Lamoureux
Singapore Eye Research Institute, Singapore, Singapore
2 shared publications - Anna Cheng Sim Tan
Singapore National Eye Centre, Singapore, Singapore
1 shared publication - Chui Ming Gemmy Cheung
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
1 shared publication Eva K. Fenwick
Duke-NUS Medical School, Singapore; Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
1 shared publication- Eva Katie Fenwick
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore
1 shared publication - Preeti Gupta
Future Health Technologies Programme, Singapore-ETH Centre, Singapore, Singapore
1 shared publication
Latest Publications
- 16 April 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 109 (7) , 822-828
Vision-related quality of life impact of age-related macular degeneration in older adults aged 60–100 years: a cross-sectional study
Background We evaluated the prevalence of age-related macular degeneration (AMD) and its interplay with age in influencing vision-related quality of life (VRQoL) in older Asians. Methods We included 2361 participants aged 60–101 years from the Population Health and Eye Disease Profile in Elderly Singaporeans cross-sectional study (2017–2022). Early and late AMD were graded using the modified Wisconsin grading system. VRQoL was assessed using Rasch-transformed overall, visual functioning and emotional well-being scores of the Brief Impact of Visual Impairment questionnaire. We calculated the prevalence of AMD and used multivariable regression models to assess the associations between AMD and age on VRQoL. VRQoL reduction was deemed clinically meaningful if ≥0.5 SD of the cohort’s baseline VRQoL scores. Results The overall prevalence of any, early and late AMD was 6.2%, 4.4% and 1.8%, respectively. The age-specific prevalence increased progressively with age; that is, any AMD (4.1%, 7.2%, 12.9%), early AMD (3.0%, 4.7%, 9.3%) and late AMD (1.1%, 2.5%, 3.5%) across the three age groups (60–79, 70–79 and 80+), respectively. Participants aged ≥80 with late AMD experienced 30.1%, 21.0% and 29.7% poorer overall, visual functioning and emotional well-being, respectively (all p≤0.001), compared with those aged 60–79 without AMD. Importantly, only those aged ≥80 with late AMD demonstrated both statistically and clinically meaningful VRQoL reductions. Conclusions AMD is prevalent in ageing Asians and has a substantial impact on visual functioning and emotional well-being. Our findings support early detection of declining visual functioning and mental health and strategies to prevent progression to late-stage AMD in older patients.
- 16 April 2025
- Published by BMJ in British Journal of Ophthalmology
- Vol. 109 (7) , 822-828
Vision-related quality of life impact of age-related macular degeneration in older adults aged 60–100 years: a cross-sectional study
Background We evaluated the prevalence of age-related macular degeneration (AMD) and its interplay with age in influencing vision-related quality of life (VRQoL) in older Asians. Methods We included 2361 participants aged 60–101 years from the Population Health and Eye Disease Profile in Elderly Singaporeans cross-sectional study (2017–2022). Early and late AMD were graded using the modified Wisconsin grading system. VRQoL was assessed using Rasch-transformed overall, visual functioning and emotional well-being scores of the Brief Impact of Visual Impairment questionnaire. We calculated the prevalence of AMD and used multivariable regression models to assess the associations between AMD and age on VRQoL. VRQoL reduction was deemed clinically meaningful if ≥0.5 SD of the cohort’s baseline VRQoL scores. Results The overall prevalence of any, early and late AMD was 6.2%, 4.4% and 1.8%, respectively. The age-specific prevalence increased progressively with age; that is, any AMD (4.1%, 7.2%, 12.9%), early AMD (3.0%, 4.7%, 9.3%) and late AMD (1.1%, 2.5%, 3.5%) across the three age groups (60–79, 70–79 and 80+), respectively. Participants aged ≥80 with late AMD experienced 30.1%, 21.0% and 29.7% poorer overall, visual functioning and emotional well-being, respectively (all p≤0.001), compared with those aged 60–79 without AMD. Importantly, only those aged ≥80 with late AMD demonstrated both statistically and clinically meaningful VRQoL reductions. Conclusions AMD is prevalent in ageing Asians and has a substantial impact on visual functioning and emotional well-being. Our findings support early detection of declining visual functioning and mental health and strategies to prevent progression to late-stage AMD in older patients.
- 1 August 2021
- Published by Elsevier in Ophthalmology
- Vol. 128 (8) , e39-E39
Re: Shang et al.: The association between vision impairment and incidence of dementia and cognitive impairment: a systematic review and meta-analysis (Ophthalmology. 2021;128:1135–1149)
- 1 August 2021
- Published by Elsevier in Ophthalmology
- Vol. 128 (8) , e39-E39
Re: Shang et al.: The association between vision impairment and incidence of dementia and cognitive impairment: a systematic review and meta-analysis (Ophthalmology. 2021;128:1135–1149)